GlassScriptPhysician profile
David P Musich
NPI 1790717676
$2,573.56
in general payments reported to CMS, 2019-2025
20 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $79.11 · 2021: $235 · 2022: $388 · 2023: $441 · 2024: $585 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,488.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $638.25 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $388.85 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $247.25 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Blue Earth Diagnostics | $195.00 | 2019-2025 | Posluma |
| Bioprotect Medical, INC. | $164.56 | 2024 | Bioprotect Balloon Implant System |
| Myriad Genetic Laboratories, INC. | $156.69 | 2022 | |
| Pfizer INC. | $143.55 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $124.77 | 2023-2025 | Orgovyx |
| Boston Scientific Corporation | $109.82 | 2019-2023 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $108.49 | 2022-2024 | Pylarify |
| Janssen Biotech, INC. | $49.55 | 2021-2023 | Erleada |
| Myovant Sciences INC. | $48.37 | 2022 | |
| Siemens Medical Solutions USA, INC. | $42.66 | 2025 | Varian Ethos Treatment Planning |
| Amgen INC. | $34.24 | 2021-2022 | |
| Masimo Corporation | $26.26 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $21.86 | 2022 | |
| Palette Life Sciences, INC. | $21.43 | 2022 | |
| Accord Healthcare, INC. | $20.05 | 2023 | |
| Ferring Pharmaceuticals INC. | $17.30 | 2019 | |
| Novocure INC. | $14.61 | 2025 | Optune Lua (Novottf-200t) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Musich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.